Last reviewed: May 20, 2026

Last updated: May 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, semaglutide has demonstrated efficacy for weight loss in clinical trials, with participants losing an average of 10-22% of body weight depending on dosage and study duration. As a GLP-1 receptor agonist, it works by regulating appetite and blood sugar, addressing multiple metabolic pathways simultaneously.

Weight loss treatment is highly individual, and understanding your unique metabolic and genetic context can support more confident decision-making. PlexusDx emphasizes precision wellness by exploring how your genetic predispositions and biomarker profile may inform whether semaglutide could be a meaningful option for you.

How Semaglutide Works: The GLP-1 Mechanism

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone that signals satiety and stabilizes blood sugar. It slows gastric emptying, increases feelings of fullness, and modulates appetite centers in the brain. This multi-system approach distinguishes it from older weight loss medications.

The drug activates GLP-1 receptors throughout the digestive system and central nervous system, creating sustained appetite suppression. Many users report reduced cravings and decreased food intake within weeks of starting treatment, though individual responses vary considerably based on genetics and metabolism.

Clinical Evidence: What the Data Shows About Weight Loss Outcomes

Multiple randomized controlled trials demonstrate semaglutide's weight loss efficacy. The STEP trials followed participants for 68 weeks, showing dose-dependent results ranging from modest to substantial weight reduction.

Semaglutide Dose Average Weight Loss % Average Weight Loss (lbs) Study Duration
0.5 mg/week 7.5% ~17 lbs 68 weeks
1.0 mg/week 10.9% ~25 lbs 68 weeks
1.7 mg/week 15.3% ~35 lbs 68 weeks
2.4 mg/week 17.4% ~40 lbs 68 weeks

Safety Profile and Common Side Effects

Semaglutide is generally well-tolerated, though gastrointestinal side effects like nausea, vomiting, and constipation occur in many users, particularly during dose escalation. These effects often diminish over time as the body adjusts. Serious adverse events are rare in clinical populations without personal or family history of thyroid cancer.

Contraindications include personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. Close monitoring is recommended for those with diabetic retinopathy or a history of pancreatitis. Your provider should thoroughly assess your medical history before initiating treatment.

Who Is a Candidate: Clinical Eligibility and Biomarker Context

Semaglutide is appropriate for individuals with BMI ≥30 or BMI ≥27 with weight-related comorbidities like hypertension or metabolic syndrome. Age, overall health, kidney and liver function, and medication interactions all inform eligibility. A thorough medical evaluation is essential before starting.

Genetic predispositions in GLP-1 receptor pathways and metabolic genes may influence how your body responds to treatment. Understanding your genetic profile can help you and your provider establish realistic expectations and optimize dosing strategies for your individual metabolism.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around your genetic predispositions in key peptide pathway genes, including GLP1R variants and related metabolic genes like FTO and MC4R. These genetic insights can support a more personalized conversation with your healthcare provider about whether semaglutide aligns with your individual biology.

Genetic predispositions in the GLP1R rs6923761 variant and other metabolic genes may influence baseline appetite regulation and weight loss responsiveness. However, it is important to understand that these genetic insights indicate predispositions, not exact medication response. Your lifestyle, medical history, and overall health remain critical factors.

Discussing your genetic predispositions alongside clinical markers like fasting glucose, insulin resistance, and metabolic syndrome status can support a more informed provider conversation. PlexusDx information should be interpreted with a qualified healthcare provider to contextualize what your genetic profile may mean for your unique situation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves